Literature DB >> 28478870

Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Roman Shrestha, Pramila Karki, Tania B Huedo-Medina, Michael Copenhaver.   

Abstract

Neurocognitive impairment (NCI) and HIV risk are significant correlates of intent to use preexposure prophylaxis (PrEP). The extent to which similar outcomes could occur when these factors operate together, particularly for people who use drugs (PWUD), remains an important unanswered question. We therefore sought evidence that HIV risk behavior mediated the relationship between NCI and intent to use PrEP in high-risk PWUD in treatment. HIV-uninfected, methadone-maintained people who reported HIV-risk behaviors were enrolled (n = 400). Variables of interest (NCI, HIV risk behaviors, intent to use PrEP) were assessed using audio computer-assisted self-interview. We found preliminary evidence of indirect effect of HIV risk behaviors, such that NCI had an increased impact on intent to use PrEP via HIV risk behaviors. As a result of having this information, clinicians and researchers will be better equipped for evidence-informed targeting and dissemination efforts to optimize PrEP uptake by this underserved population.
Copyright © 2017 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV prevention; HIV risk behaviors; methadone maintenance treatment; neurocognitive impairment; people who use drugs; preexposure prophylaxis

Mesh:

Year:  2017        PMID: 28478870      PMCID: PMC7451137          DOI: 10.1016/j.jana.2017.04.005

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  34 in total

1.  The neuropsychology of cocaine addiction: recent cocaine use masks impairment.

Authors:  Patricia A Woicik; Scott J Moeller; Nelly Alia-Klein; Thomas Maloney; Tanya M Lukasik; Olga Yeliosof; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein
Journal:  Neuropsychopharmacology       Date:  2008-05-21       Impact factor: 7.853

2.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

3.  Cognitive deficits predict low treatment retention in cocaine dependent patients.

Authors:  Efrat Aharonovich; Deborah S Hasin; Adam C Brooks; Xinhua Liu; Adam Bisaga; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2005-09-19       Impact factor: 4.492

4.  The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.

Authors:  Nora D Volkow; Julio Montaner
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

5.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.

Authors:  Ifeoma Ezeabogu; Michael M Copenhaver; Jessica Potrepka
Journal:  AIDS Care       Date:  2012-01-17

7.  Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.

Authors:  Roman Shrestha; Tania B Huedo-Medina; Frederick L Altice; Archana Krishnan; Michael Copenhaver
Journal:  AIDS Behav       Date:  2017-11

8.  Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study.

Authors:  Ramona Bhatia; Christine Hartman; Michael A Kallen; James Graham; Thomas P Giordano
Journal:  AIDS Behav       Date:  2011-08

9.  The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review.

Authors:  Pramila Karki; Roman Shrestha; Tania B Huedo-Medina; Michael Copenhaver
Journal:  Evid Based Med Public Health       Date:  2016-03-22

10.  Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials.

Authors:  David J Finitsis; Jennifer A Pellowski; Blair T Johnson
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more
  6 in total

1.  Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Oleksandr Dubov; Liana Fraenkel; Tania Huedo-Medina; Michael Copenhaver
Journal:  AIDS Behav       Date:  2018-04

2.  Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.

Authors:  K B Biello; A R Bazzi; M J Mimiaga; D L Biancarelli; A Edeza; P Salhaney; E Childs; M L Drainoni
Journal:  Harm Reduct J       Date:  2018-11-12

3.  Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review.

Authors:  Rogério M Pinto; Ashley Lacombe-Duncan; Emma Sophia Kay; Kathryn R Berringer
Journal:  AIDS Behav       Date:  2019-10

4.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05

5.  Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.

Authors:  Sheri L Towe; Catherine A Sullivan; Mehri S McKellar; Christina S Meade
Journal:  AIDS Behav       Date:  2021-05

6.  Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment.

Authors:  Michael M Copenhaver; Victoria Sanborn; Roman Shrestha; Colleen B Mistler; Matthew C Sullivan; John Gunstad
Journal:  Drug Alcohol Depend       Date:  2021-04-24       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.